www.aging-us.com AGING 2021, Vol. 13, No. 5 Research Paper Prognostic significance of epigenetic regulatory gene expression in patients with non-small-cell lung cancer Zegui Tu1,2, Xiancheng Chen4, Tian Tian1,2, Guo Chen5, Meijuan Huang1,2,3 1Department of Thoracic Oncology, West China Hospital of Sichuan University, Chengdu 610041, Sichuan, P.R. China 2West China Medical School, Sichuan University, Chengdu 610041, P.R. China 3State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, P.R. China 4State Key Laboratory of Biotherapy, Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, P.R. China 5Global Infotech Software Limited Corporation, Chengdu 610041, Sichuan, P.R. China Correspondence to: Meijuan Huang; email:
[email protected], https://orcid.org/0000-0002-3390-9697 Keywords: epigenetic regulatory genes, non-small-cell lung cancer, expression patterns, prognosis Received: May 28, 2020 Accepted: November 8, 2020 Published: February 26, 2021 Copyright: © 2021 Tu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ABSTRACT In this study, we used public databases to investigate the prognostic significance of epigenetic regulatory gene expression in patients with non small-cell lung cancer (NSCLC). Oncomine database analysis showed that the mRNA levels of seven epigenetic regulatory genes, UHRF1, EZH2, TTF2, SUV39H2, PCNA, WHSC1 and RAD54L, genes were significantly upregulated in NSCLC patients as compared to normal lung tissues.